当前位置: X-MOL 学术J. Urol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
A Comparison of Percutaneous Ablation Therapy to Partial Nephrectomy for cT1a Renal Cancers: Results from the Canadian Kidney Cancer Information System (CKCis).
The Journal of Urology ( IF 6.6 ) Pub Date : 2022-06-10 , DOI: 10.1097/ju.0000000000002798
Braden Millan 1 , Rodney H Breau 2 , Bimal Bhindi 3 , Ranjeeta Mallick 4 , Simon Tanguay 5 , Antonio Finelli 6 , Luke T Lavallée 2 , Frédéric Pouliot 7 , Ricardo Rendon 8 , Alan I So 9 , Lucas Dean 10 , Jean-Baptiste Lattouf 11 , Naveen S Basappa 12 , Anil Kapoor 1
Affiliation  

Percutaneous ablation therapy (AT) and partial nephrectomy (PN) are successful management strategies for T1a renal cancer. Our objective was to compare AT to PN with respect to recurrence-free survival (RFS) and overall survival (OS).

中文翻译:

cT1a 肾癌经皮消融治疗与肾部分切除术的比较:来自加拿大肾癌信息系统 (CKCis) 的结果。

经皮消融治疗 (AT) 和肾部分切除术 (PN) 是 T1a 期肾癌的成功治疗策略。我们的目标是在无复发生存期 (RFS) 和总生存期 (OS) 方面比较 AT 和 PN。
更新日期:2022-06-10
down
wechat
bug